The GME studies show, the Vaccine
Market is expected to grow at a higher CGAR percentage of 8.5 between
2020-2026 duration. The high prevalence of infectious disease and the growing
focus on immunization is creating the demand for the product. Government
investment to bring immunization to a every stratum of the society is building
opportunities for the growth of the product. A global pandemic has affected
more than 200 million of the global population. This created pressure on the
manufacturing companies to increase the production rate and escalate the supply
chain of the product. The expansion of manufacturing commodities facilitates
catering to the demand will further strengthen the core potential of many
industries.
Browse 196 Market Data Tables and 115
Figures spread through 173 Pages on "Global Vaccine Market -
Forecasts to 2026" https://www.globalmarketestimates.com/market-report/global-vaccine-market-2443
By Technology (Live Attenuated Vaccines, Toxoid Vaccines,
Recombinant Vaccines, Inactivated Vaccines, and
Other Vaccines); By Disease (Pneumococcal, Influenza, DTP, Rotavirus,
TT, Polio, MMR, Varicella, Dengue and TB); By Route(IM, SC, ID, and Oral); By
Patient (Pediatric, and Adult); By Region (North America, Europe, Asia Pacific,
MEA, and CSA); By Region (North America, Europe, Asia Pacific, MEA, and CSA),
Company Market Share & Competitor Analysis
Key
Market Insights:
·
The Global
Vaccine market is expected grow with a CAGR value of 8.5% during
2020-2026
·
The inactivated vaccines have shown the highest
market since past recent times.
·
Diseases such as pneumococcal, DTP, and others come
under bacterial diseases which holds the largest market share of the vaccines
·
The intramuscular and intra-cutaneous administration
accounts for the largest vaccine market share of 2019 and is estimated to
witness the same growth in the aforementioned timeline owing to the increased
prevalence of bacterial and viral diseases.
·
Pediatric holds the largest market of the vaccine in
terms of value. The two prime reasons behind the significant growth are
increasing pediatric vaccination dosage and increasing statistics of birth.
·
North
America showed the highest market share of vaccines in the year 2019 and
expected to maintain dominance in the coming years also.
Key
global players in the Global Vaccine
market include: GlaxoSmithKline plc.
(UK), Pfizer, Inc. (US), Merck & Co., Inc. (US), Sanofi Pasteur SA
(France), CSL Limited (Australia), Emergent BioSolutions, Inc. (US), Johnson
& Johnson (US), Serum Institute of India (India), AstraZeneca (UK),
Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), and
Daiichi Sankyo Company, Limited (Japan) among others.
Browse the Global Vaccine market
Report @: https://www.globalmarketestimates.com/market-report/global-vaccine-market-2443
·
Technology
Outlook (Revenue, USD Billion, 2020 - 2026)
Ø
Live Attenuated Vaccines
Ø
Toxoid Vaccines
Ø
Recombinant Vaccines
Ø
Inactivated Vaccines
Ø
Other Vaccines
·
Disease Outlook (Revenue, USD Billion, 2020 -
2026)
Ø
Pneumococcal
Ø
Influenza
Ø
DTP
Ø
Rotavirus
Ø
TT
Ø
Polio
Ø
MMR
Ø
Varicella
Ø
Dengue
Ø
TB
·
Route
Outlook (Revenue, USD Billion, 2020 - 2026)
Ø
IM
Ø
SC
Ø
ID
Ø
Oral
·
PatientOutlook
(Revenue, USD Billion, 2020 - 2026)
Ø
Pediatric
Ø
Adult
·
Regional Outlook (Revenue, USD Billion, 2020 -
2026)
Ø
North America
o
U.S.
o
Canada
o
Mexico
Ø
Europe
o
Germany
o
UK
o
France
o
Spain
o
Italy
o
Rest of Europe
Ø
Asia Pacific
o
China
o
India
o
Japan
o
South Korea
o
Australia
o
Rest of APAC
Ø
Central & South America
o
Brazil
o
Argentina
o
Chile
o
Rest of CSA
Ø
Middle East & Africa
o
Saudi Arabia
o
South Africa
o
UAE
o
Rest of MEA
Contact: Yash Jain
Email address: sales@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
No comments:
Post a Comment